CompletedNot Applicable

Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT）

China10 participantsStarted 2022-10-11

Plain-language summary

The purpose of this study was to explore the safety and efficacy of a Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter in the treatment of Paroxysmal Supraventricular Tachycardia.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with symptomatic paroxysmal supraventricular tachycardia including:Atrioventricular nodal re-entrant tachycardia, Atrioventricular arrhythmias;
. Willingness to undergo an evaluation to validate the requirements of the protocol.
. Voluntary signed informed consent and willingness to undergo the tests and procedures required by the protocol.

Exclusion criteria

. Patients with structural heart disease
. History of any cardiac surgery
. Failure of prior ablation of PSVT
. Presence of any implantation, such as artificial valves, permanent pacemakers, etc
. Patients with active systemic infections
. Any condition contraindicating septal puncture or retrograde transaortic approach for procedures
. Any condition contraindicating heparin or aspirin
. Patients with advanced malignant tumor

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Immediate ablation success rate

Timeframe: 15 minutes post ablation

Rate of Treatment Success at 6-Month Post-Procedure

Timeframe: Refers to the postoperative phase after 6 months postoperatively

Trial details

NCT IDNCT05770921

SponsorNingbo No. 1 Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-01

View on ClinicalTrials.gov More Paroxysmal Supraventricular Tachycardia trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with symptomatic paroxysmal supraventricular tachycardia including:Atrioventricular nodal re-entrant tachycardia, Atrioventricular arrhythmias;
. Willingness to undergo an evaluation to validate the requirements of the protocol.
. Voluntary signed informed consent and willingness to undergo the tests and procedures required by the protocol.

Exclusion criteria

. Patients with structural heart disease
. History of any cardiac surgery
. Failure of prior ablation of PSVT
. Presence of any implantation, such as artificial valves, permanent pacemakers, etc
. Patients with active systemic infections
. Any condition contraindicating septal puncture or retrograde transaortic approach for procedures
. Any condition contraindicating heparin or aspirin
. Patients with advanced malignant tumor